hmg 3

Apomine (SR-9223i) 是一种 HMG-CoA-还原酶抑制剂，可在体外促进骨髓瘤细胞的凋亡，并与体内骨髓瘤的调节有关。 Apomine 加速 3-羟基-3-甲基戊二酰-CoA 还原酶的降解并刺激低密度脂蛋白受体活性。 Apomine 通过下调 3-羟基-3-甲基戊二酰-CoA 还原酶来增强洛伐他汀对骨髓瘤细胞的抗肿瘤作用。

Atorvastatin lactone 是一种 Atorvastatin 的前药。其中 Atorvastatin 是口服具有活力的 3- 羟基 -3- 甲基戊二酰辅酶 A 还原酶抑制剂。

O-Methyl Atorvastatin is an impurity of Atorvastatin that is an orally active inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, has the ability to effectively decrease blood lipids.

(3S,5S)-Pitavastatin calcium is the 3-epimer of Pitavastatin which is a potent HMG-CoA reductase inhibitor.

Hymeglusin 是一种选择性 3-羟基-3-甲基戊二酰辅酶 A (HMG-CoA) 合酶 1 抑制剂，也是一种抗生素，可降低 HL-60 和 KG-1 细胞中 BCL2 的表达水平，可用于研究白血病。

3-Oxo Atorvastatin, an impurity of Atorvastatin, acts as an HMG-CoA reductase inhibitor and effectively decreases blood lipids.

7-Ketocholesterol 是胆固醇的代谢物。

Meglutol (3-Hydroxy-3-methylglutaric acid) 是一种抗血脂剂，可降低胆固醇、甘油三酯、血清 β-脂蛋白和磷脂。它抑制胆固醇生物合成中的限速酶羟甲基戊二酰辅酶 A 还原酶的活性。

Pitavastatin-d4 Sodium Salt 是 Pitavastatin Sodium Salt 的氘代化合物。Pitavastatin Sodium Salt 的 CAS 号为 574705-92-3。

(Rac)-3′-Hydroxy simvastatin 是一种 Simvastatin 代谢物。Simvastatin 是一种竞争性的 HMG-CoA 还原酶抑制剂，Ki 值为 0.2 nM。

β-Muricholic acid (β-MCA) is a murine-specific primary bile acid.[1],[2] Dietary administration of β-MCA reduces HMG-CoA reductase activity in liver microsomes from mice fed a high cholesterol and cholic acid diet.[3] Dietary administration of β-MCA also dissolves 100% of gallstones in a gallstone-susceptible mouse model of diet-induced cholesterol gallstones.[4]

Pitavastatin (NK-104) 是一种 3-羟基-3-甲基戊二酰辅酶A（HMG-CoA）还原酶抑制剂，具有降胆固醇和神经保护活性，抑制乙酸合成胆固醇，可减少氧化应激。Pitavastatin 是一种肝细胞低密度脂蛋白胆固醇 (LDL-C) 受体诱导剂，可用于研究冠状动脉粥样硬化、高胆固醇血症和急性冠脉综合征。Pitavastatin 结构不稳定，建议现用现配。

(3R,5S)-Fluvastatin ((3R,5S)-XU 62-320) sodium 为Fluvastatin的一个3R,5S-立体异构体。该化合物(Fluvastatin (XU 62-320 free acid)) 是首个全合成、具有竞争性的HMG-CoA还原酶抑制剂，具有8 nM的IC50值。此外，Fluvastatin还能通过Nrf2依赖的抗氧化途径，保护血管平滑肌细胞不受氧化应激影响。

Geranylgeranyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway derived directly from farnesyl pyrophosphate and used in the biosynthesis of terpenes and terpenoids.[1] It is also serves as a substrate in the prenylation of a variety of critical intracellular proteins including small GTPases.[2] This post-translational modification is necessary for correct localization of proteins to intracellular membranes for proper functionality and has become a focus of anticancer drug discovery.[3][4]

Atorvastatin 3-Deoxyhept-2E-Enoic Acid is an impurity of Atorvastatin, an HMG-CoA reductase inhibitor that effectively decreases blood lipids.

N-desmethyl Rosuvastatin is an active metabolite of the HMG-CoA reductase inhibitor rosuvastatin .1,2N-desmethyl Rosuvastatin is formed when rosuvastatin undergoes demethylation, primarily by the cytochrome P450 (CYP) isoform CYP2C9 and to a lesser extent by CYP2C19 and CYP3A4.1 1.Macwan, J.S., Ionita, I.A., and Akhlaghi, F.A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS)Anal. Bioanal. Chem.402(3)1217-1227(2012) 2.Bai, X., Wang, X.P., He, G.D., et al.Simultaneous determination of rosuvastatin, rosuvastatin-5 S-lactone, and N-desmethyl rosuvastatin in human plasma by UPLC-MS/MS and its application to clinical studyDrug Res. (Stuttg.)68(6)328-334(2018)